Janux Therapeutics, Inc.

The current price of JANX is 47.17 USD — it has decreased by 2.17% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Janux Therapeutics, Inc. stocks are traded under the ticker JANX.

Janux Therapeutics, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.

JANX stock is 5.74% volatile and has beta coefficient of 3.64. Check out the list of the most volatile stocks — is Janux Therapeutics, Inc. there?

JANX earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.47 USD resulting in a 46.81% surprise. The estimated earnings for the next quarter are −0.42 USD per share. See more details about Janux Therapeutics, Inc. earnings.

Janux Therapeutics, Inc. revenue for the last quarter amounts to ‪2.52 M‬ USD despite the estimated figure of ‪845.50 K‬ USD. In the next quarter revenue is expected to reach ‪750.00 K‬ USD.

Yes, you can track Janux Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

JANX stock has fallen by 1.47% compared to the previous week, the month change is a 21.25% rise, over the last year Janux Therapeutics, Inc. has showed a 221.73% increase.

Today Janux Therapeutics, Inc. has the market capitalization of ‪2.49 B‬, it has decreased by 3.30% over the last week.

No, JANX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, JANX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Janux Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

JANX reached its all-time high on Feb 28, 2024 with the price of 58.69 USD, and its all-time low was 5.65 USD and was reached on Nov 10, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 64.00 employees. See our rating of the largest employees — is Janux Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Janux Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Janux Therapeutics, Inc. stock shows the strong buy signal. See more of Janux Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Janux Therapeutics, Inc. future price: according to them, JANX price has a max estimate of 100.00 USD and a min estimate of 25.00 USD. Read a more detailed Janux Therapeutics, Inc. forecast: see what analysts think of Janux Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Janux Therapeutics, Inc. EBITDA is ‪−71.02 M‬ USD, and current EBITDA margin is −878.68%. See more stats in Janux Therapeutics, Inc. financial statements.